| Excell Care Rehabilitation | |
|
2008 W Northside Dr, Clinton, MS 39056-3015 | |
| (601) 926-4628 | |
| Not Available |
| Full Name | Excell Care Rehabilitation |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 2008 W Northside Dr, Clinton, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134364607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Excell Care Rehabilitation 2008 W Northside Dr, Clinton, MS 39056-3015 Ph: (601) 926-4628 | Excell Care Rehabilitation 2008 W Northside Dr, Clinton, MS 39056-3015 Ph: (601) 926-4628 |
News Archive
The Los Angeles Times: "The abrupt resignation last month of Anthem Blue Cross' president is offering a glimpse of an internal struggle that has roiled California's largest for-profit health insurer for months. Leslie Margolin was the public face of Anthem this year when it sought to raise individual insurance rates as much as 39%.
A US study presented today at The International Liver CongressTM 2012 demonstrates that the entire HCV lifecycle can be recapitulated in murine cells, implying that HCV permissive mouse models could soon be developed.
Ambit Biosciences, today announced that it has initiated separate Phase I trials for two products AC430, a selective Janus Kinase 2 (JAK2) inhibitor, and AC480, a pan-HER inhibitor.
University of Arizona researchers have found in a recent study that ultrasound waves applied to specific areas of the brain appear able to alter patients' moods. The discovery has led the scientists to conduct further investigations with the hope that this technique could one day be used to treat conditions such as depression and anxiety.
The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).
› Verified 6 days ago
Alicia Broadway Swann, AUDIOLOGIST Audiologist Medicare: Not Enrolled in Medicare Practice Location: 541 Highway 80 W, Suite C, Clinton, MS 39056 Phone: 601-488-4189 Fax: 601-488-4888 |